SCHEMBL4201495

SCHEMBL4201495

CCOC(=O)c1ccccc1OC(=O)OCC(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
TSHR P16473 3/20 0.59
HSD17B10 Q99714 3/20 0.49
MAPT P10636 5/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TP53 P04637 1/20 0.46
NPY1R P25929 1/20 0.46
NPY2R P49146 1/20 0.46
ATM Q13315 1/20 0.46
KDM4E B2RXH2 4/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
NPC1 O15118 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1283916 0.88 ALDH1A1 (0.72) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL4391361 0.88 TSHR (0.67) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL1283310 0.86 TSHR (0.69) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL2910803 0.85 KDM4E (0.63) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL28020536 0.84 TSHR (0.61) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL5706067 0.83 TSHR (0.65) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL1142993 0.83 ALDH1A1 (0.86) ALDH1A1TSHRHSD17B10MAPTMEN1
Diethyl Phthalate SCHEMBL5152078 0.83 ALDH1A1 (0.86) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL10344219 0.83 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10MAPTMEN1
SCHEMBL4200313 0.82 TSHR (0.59) ALDH1A1TSHRHSD17B10MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE XENOPORT, INC. 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076147-A1 COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE ADSL, SLC19A1, SLC25A21 ALDH1A1 1514/4885TSHR 2112/4885HSD17B10 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.